| 481/892 | US=23 / Câncer Kelly CMA, Ryan DN, Penny SA, Gallagher WM. Systematic validation of breast cancer biomarkers using tissue microarrays: from construction to image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 235-50. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TISSUE MICROARRAYS (TMA); VALIDACAO SISTEMATICA DE BIOMARCADORES; CONSTRUCAO DA IMAGEM; ANALISE DE IMAGEM; PELLET CELULAR; IMUNOHISTOQUIMICA |
| 482/892 | US=23 / Câncer Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS |
| 483/892 | US=23 / Câncer Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA |
| 484/892 | US=23 / Câncer Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO |
| 485/892 | US=23 / Câncer van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE |
| 486/892 | US=23 / Câncer Kaufmann M, Loibl S, von Minckwitz G. Operable breast cancer: neoadjuvant treatment (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 305-18. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA OPERAVEL; TRATAMENTO NEOADJUVANTE; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO |
| 487/892 | US=23 / Câncer McCubrey JA, Franklin RA, Navolanic PM, Martelli AM, Steelman LS. Chemotherapy for breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 319-25. ISBN 978-1-4020-8368-6. CANCER DE MAMA; QUIMIOTERAPIA; METOTREXATO; 5-FLUOROURACIL; CICLOFOSFAMIDA; ANTRACICLINA; TAXANOS; TRASTUZUMABE; TAMOXIFENO; INIBIDORES DE AROMATASE |
| 488/892 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, D'Aiuto M, Comella G. Locally advanced breast cancer: role of chemotherapy in improving prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 327-49. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; QUIMIOTERAPIA; QUIMIOTERAPIA PRE-OPERATORIA; QUIMIOTERAPIA POS-OPERATORIA; TRATAMENTO NEOADJUVANTE; TERAPIA-ALVO |
| 489/892 | US=23 / Câncer Kummel S, Rezai M, Kimmig R, Schmid P. Relevance of dose-intensity for adjuvant treatment of breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 351-60. ISBN 978-1-4020-8368-6. |
| 490/892 | US=23 / Câncer Pallis AG, Georgoulias V, Mavroudis V. Advanced breast cancer: treatment with docetaxel/epirubicin. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 361-71. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA AVANCADO; CANCER DE MAMA. TRATAMENTO; DOCETAXEL; EPIRRUBICINA; COMBINACAO ANTRACICLINA-TAXANO; COMBINACAO DOCETAXEL EPIRRUBICINA; DADOS FARMACOCINETICOS |
| 491/892 | US=23 / Câncer Erban JK, Lau J. Systemic therapy for breast cancer: using toxicity data to inform decisions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 373-94. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TERAPIA SISTEMICA; DADOS DE TOXICIDADE; TERAPIA HORMONAL; QUIMIOTERAPIA; TERAPIAS-ALVO; TOXICIDADE AGUDA; SEQUELAS |
| 492/892 | US=23 / Câncer Morabito A, Piccirillo MC, Bryce J, Monaco K, De Feo G, Del Giudice A, Falasconi F, Perrone F. Chemotherapy for metastatic breast cancer patients who received adjuvant anthracyclines (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 395-414. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA METASTATICO; QUIMIOTERAPIA; ANTRACICLINAS ADJUVANTES; HER-2 |
| 493/892 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, Thomas R, D'Aiuto M, Comella G. Estrogen receptor-negative and HER-2/neu-positive locally advanced breast carcinoma: therapy with paclitaxel and granulocyte-colony stimulating factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 415-32. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA; ESTROGENIO; RECEPTOR-NEGATIVO; HER-2/NEU-POSITIVE; PACLITAXEL; COLONIAS DE GRANULOCITOS; RECEPTORES HORMONAIS; RESPOSTA A QUIMIOTERAPIA |
| 494/892 | US=23 / Câncer Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE |
| 495/892 | US=23 / Câncer Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6. CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE |
| 496/892 | US=23 / Câncer Bafford AC, Garber JE, Chittenden A, Golshan M. Young breast cancer patients undergoing breast-conserving therapy: role of BRCA1 and BRCA2. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 483-91. ISBN 978-1-4020-8368-6. CANCER DE MAMA; PACIENTES JOVENS; TERAPIA CONSERVADORA DA MAMA; BRCA1; BRCA2 |
| 497/892 | US=23 / Câncer Smith BD. Radiation therapy for older women with early breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 493-506. ISBN 978-1-4020-8368-6. |
| 498/892 | US=23 / Câncer Tan XL, Popanda O, Chang-Claude J. Acute side effects of radiotherapy in breast cancer patients: role of DNA-repair and cell cycle control genes. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 507-28. ISBN 978-1-4020-8368-6. CANCER DE MAMA; RADIOTERAPIA; EFEITOS COLATERAIS; REPARO DO DNA; CELULAS GENES; CONTROLE DE CICLO |
| 499/892 | US=23 / Câncer Kumar R, Lal N. 18F-Fluorodeoxyglucose/positron emission tomography in primary breast cancer: factors responsible for false-negative results. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 529-41. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TOMOGRAFIA POR EMISSAO DE POSITROS; 18F-FLUORODEOXIGLUCOSE; RESULTADOS FALSO-NEGATIVOS; TAMANHO TUMORAL; TIPO HISTOLOGICO; GRAU DO TUMOR; PADROES DE CRESCIMENTO DE TUMOR; ATIVIDADE PROLIFERATIVA; DENSIDADE DE VASOS SANGUINEOS DO TUMOR; HETEROGENEIDADE DO TECIDO; LESOES DE MAMA UNIFOCAL; LESOES DE MAMA MULTIFOCAL; RECEPTOR DE ESTROGENO; RECEPTOR DE PROGESTERONA; DENSIDADE DA MAMA; PROPAGACAO AXILAR; PROPAGACAO DISTANTE; NIVEIS DE GLICOSE NO SANGUE; TRANSPORTADORES DE GLICOSE; AQUISICAO DE DADOS; ANALISE DE DADOS |
| 500/892 | US=23 / Câncer Boughey JC, Bedrosian I. Sentinel lymph node surgery during prophylactic mastectomy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 543-56. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO SENTINELA; CIRURGIA; MASTECTOMIA PROFILATICA |